Torrey C Brown

Title: Torrey C Brown: Innovator in Bacteriophage Research

Introduction

Torrey C Brown is a notable inventor based in Severna Park, MD (US). He has made significant contributions to the field of bacteriophage research, holding three patents that focus on reducing bacterial colonization in susceptible patients.

Latest Patents

One of his latest patents is titled "Reduction in bacterial colonization by administering bacteriophage compositions." This invention provides a method for reducing the risk of bacterial infection or sepsis in susceptible patients. The method involves treating patients with a pharmaceutical composition containing bacteriophage strains that produce lytic infections in pathogenic bacteria. The treatment aims to reduce the level of colonization with pathogenic bacteria by at least one log. The typical patients targeted by this method include those who are immunocompromised, such as leukemia, lymphoma, carcinoma, and sarcoma patients, as well as allogeneic transplant patients and individuals with congenital or acquired immunodeficiency, cystic fibrosis, or AIDS.

Career Highlights

Torrey C Brown is associated with Intralytix, Inc., where he continues to advance his research in bacteriophage therapy. His work is pivotal in developing innovative solutions to combat bacterial infections, particularly in vulnerable patient populations.

Collaborations

Some of his notable coworkers include Alexander Sulakvelidze and J Glenn Morris, who contribute to the collaborative efforts in bacteriophage research and development.

Conclusion

Torrey C Brown's innovative work in bacteriophage therapy represents a significant advancement in medical science, particularly for immunocompromised patients. His contributions through patents and collaboration with esteemed colleagues continue to pave the way for new therapeutic approaches.